Redwood City, CA, United States of America

Steven P Braithwaite

This inventor holds 13 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Blood Plasma Therapy. Top assignees: Alkahest, Inc., Rutgers, The State University of New Jersey, Leland Stanford Junior University. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven P Braithwaite. Retrieved from https://idiyas.com/inventor/steven-p-braithwaite

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 61(Granted Patents)


Location History:

  • San Francisco, CA (US) (2021)
  • Redwood City, CA (US) (2016 - 2022)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cognitive Disorders
Blood Plasma
Aging
Therapy
Tumor Growth
Dosing Regimen
CCR3-Inhibitors
Motor Impairments
Immunocompromised Models
Dyskinesia
13 patents (USPTO):Explore Patents

Title: Innovations of Steven P Braithwaite

Introduction

Steven P Braithwaite is a notable inventor based in Redwood City, California. He has made significant contributions to the field of cognitive and motor impairment treatments, holding a total of 12 patents. His work focuses on innovative methods and compositions that utilize blood plasma and its derivatives to address aging-related conditions.

Latest Patents

Among his latest patents, Braithwaite has developed a dosing regimen for the treatment of cognitive and motor impairments using blood plasma and blood plasma products. This patent describes methods and compositions aimed at treating and preventing aging-related conditions, particularly cognitive disorders. The compositions include blood plasma and fractions derived from it, demonstrating efficacy in improving cognitive functions. Another significant patent involves methods for treating aging-associated impairments using CCR3-inhibitors. This innovation provides methods for improving neurodegenerative diseases by administering CCR3 modulating agents, which can enhance cognition and motor functions in affected individuals.

Career Highlights

Throughout his career, Braithwaite has worked with prominent organizations such as Alkahest, Inc. and Rutgers, the State University of New Jersey. His experience in these institutions has allowed him to advance his research and develop groundbreaking treatments for cognitive and motor impairments.

Collaborations

Some of his notable coworkers include S Sakura Minami and Ian Gallager. Their collaborative efforts have contributed to the success of his innovative projects and patents.

Conclusion

Steven P Braithwaite's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of cognitive and motor impairments. His contributions through patents and collaborations continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…